Literature DB >> 24449079

[Renaissance of pedicled flaps in oral and maxillofacial surgery].

M Twieg1, W Reich, R Dempf, A W Eckert.   

Abstract

A retrospective analysis in the period 2007 to 2011 included 71 surgically treated patients for carcinoma of the head and neck region and subsequent reconstruction with 36 pedicled distant flaps and 47 free flaps. Patient specific parameters of data collection with SPSS 17.0 were age and sex distribution, TNM stage and treatment. The specific type of flap reconstruction, duration of surgery, complications, intensive care and inpatient treatment were recorded. The results showed that the healing process was uneventful in 26 (72.2 %) pedicled flaps, 14 (38.9 %) pedicled flaps were transplanted in a preoperatively irradiated area of the head and neck region and in 86.0 % with a positive healing process. Tumor stage, general physical condition of the patient and type of therapy are the key parameters for the choice of reconstruction.

Entities:  

Mesh:

Year:  2014        PMID: 24449079     DOI: 10.1007/s00104-013-2638-1

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  25 in total

1.  The role of clinical versus histopathological staging in patients with advanced oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy followed by radical surgery.

Authors:  Matthias Kreppel; Timo Dreiseidler; Daniel Rothamel; Hans-Theodor Eich; Uta Drebber; Joachim E Zöller; Martin Scheer
Journal:  J Craniomaxillofac Surg       Date:  2012-06-23       Impact factor: 2.078

2.  [Reconstructive surgery in the head-neck region: role of infraclavicular M. pectoralis major muscle flap].

Authors:  F Bootz
Journal:  HNO       Date:  2006-07       Impact factor: 1.284

3.  Comparison between free flap and pectoralis major pedicled flap for reconstruction in oral cavity cancer patients--a quality of life analysis.

Authors:  Chih-Yu Hsing; Yong-Kie Wong; Ching Ping Wang; Chen-Chi Wang; Rong-San Jiang; Fun-Jou Chen; Shih-An Liu
Journal:  Oral Oncol       Date:  2011-04-17       Impact factor: 5.337

4.  Analysis of 49 cases of flap compromise in 1310 free flaps for head and neck reconstruction.

Authors:  Peirong Yu; David W Chang; Michael J Miller; Gregory Reece; Geoffrey L Robb
Journal:  Head Neck       Date:  2009-01       Impact factor: 3.147

5.  ASA classification and perioperative variables as predictors of postoperative outcome.

Authors:  U Wolters; T Wolf; H Stützer; T Schröder
Journal:  Br J Anaesth       Date:  1996-08       Impact factor: 9.166

6.  Pectoralis major flap for head and neck reconstruction in era of free flaps.

Authors:  V D Kekatpure; N P Trivedi; B V Manjula; A Mathan Mohan; G Shetkar; M A Kuriakose
Journal:  Int J Oral Maxillofac Surg       Date:  2012-01-18       Impact factor: 2.789

7.  Axial and random pattern flaps.

Authors:  I A McGregor; G Morgan
Journal:  Br J Plast Surg       Date:  1973-07

8.  Indications for pedicled pectoralis major flap in a free tissue transfer practice.

Authors:  Daniel S Schneider; Vivian Wu; Mark K Wax
Journal:  Head Neck       Date:  2011-11-15       Impact factor: 3.147

9.  Neoadjuvant radiotherapy of head and neck carcinoma: an obstacle for plastic reconstruction?

Authors:  Stefan Riml; Franz Böhler; Lorenz Larcher; Alexander de Vries; Wolfgang Elsässer; Peter Kompatscher
Journal:  Wien Klin Wochenschr       Date:  2012-08-01       Impact factor: 1.704

10.  Analysis of 120 pectoralis major flaps for head and neck reconstruction.

Authors:  Young Sun You; Chul Hoon Chung; Yong Joon Chang; Kuyl Hee Kim; Sung Won Jung; Young Soo Rho
Journal:  Arch Plast Surg       Date:  2012-09-12
View more
  1 in total

1.  Change in reimbursement and costs in German oncological head and neck surgery over the last decade: ablative tongue cancer surgery and reconstruction with split-thickness skin graft vs. microvascular radial forearm flap.

Authors:  Sebastian Hoefert; Oliver Lotter
Journal:  Clin Oral Investig       Date:  2017-11-09       Impact factor: 3.573

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.